192 related articles for article (PubMed ID: 23979981)
1. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.
Liang J; Zhang X; Xie S; Zhou X; Shi Q; Hu J; Wang W; Qi W; Yu R
Med Oncol; 2014 Apr; 31(4):899. PubMed ID: 24573640
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
Zhang Y; Yao L; Zhang X; Ji H; Wang L; Sun S; Pang D
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1245-53. PubMed ID: 21691749
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.
Dai W; Yao Y; Zhou Q; Sun CF
PLoS One; 2014; 9(1):e87148. PubMed ID: 24466336
[TBL] [Abstract][Full Text] [Related]
5. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma.
Wang H; Li YP; Chen JH; Yuan SF; Wang L; Zhang JL; Yao Q; Li NL; Bian JF; Fan J; Yi J; Ling R
Tumour Biol; 2013 Jun; 34(3):1635-9. PubMed ID: 23412977
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer.
Ning J; Zhang J; Liu W; Lang Y; Xue Y; Xu S
Eur J Histochem; 2012 Nov; 56(4):e46. PubMed ID: 23361242
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 22 is associated with poor prognosis in neuroblastoma.
Zhibo Q; Lianxin L
Adv Clin Exp Med; 2020 Mar; 29(3):295-300. PubMed ID: 32216173
[TBL] [Abstract][Full Text] [Related]
9. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
10. USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Li J; Wang Z; Li Y
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1291-7. PubMed ID: 22447106
[TBL] [Abstract][Full Text] [Related]
11. High USP22 expression indicates poor prognosis in hepatocellular carcinoma.
Tang B; Tang F; Li B; Yuan S; Xu Q; Tomlinson S; Jin J; Hu W; He S
Oncotarget; 2015 May; 6(14):12654-67. PubMed ID: 25909224
[TBL] [Abstract][Full Text] [Related]
12. Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma.
Wang Z; Zhu L; Guo T; Wang Y; Yang J
Hum Pathol; 2015 Jul; 46(7):1006-14. PubMed ID: 25971547
[TBL] [Abstract][Full Text] [Related]
13. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
14. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
15. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma.
Piao S; Ma J; Wang W; Liu Y; Zhang M; Chen H; Guo F; Zhang B; Guo F
Oral Oncol; 2013 Aug; 49(8):796-801. PubMed ID: 23664741
[TBL] [Abstract][Full Text] [Related]
17. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
19. Is co-expression of USP22 and HSP90 more effective in predicting prognosis of gastric cancer?
Zheng H; Yu J; Li W; Yang D; Gao C; Zhang Q; Xu L
Pathol Res Pract; 2019 Apr; 215(4):653-659. PubMed ID: 30598339
[TBL] [Abstract][Full Text] [Related]
20. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
